logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11649227 B1

PDFFull Text
Date of Patent:
May. 16, 2023

Filed:

Apr. 02, 2021

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease

Applicant:

Petra Pharma Corporation, New York, NY (US);

Inventors:

Erin Danielle Anderson, Boulder, CO (US);

Sean Douglas Aronow, Boulder, CO (US);

Nicholas A. Boyles, Hillsboro, OR (US);

Markus K. Dahlgren, Shelton, CT (US);

Shulu Feng, Ridgewood, NJ (US);

Aleksey I. Gerasyuto, Flemington, NJ (US);

Eugene R. Hickey, Danbury, CT (US);

Thomas Combs Irvin, Erie, CO (US);

Edward A. Kesicki, New York, NY (US);

Anke Klippel-Giese, Princeton, NJ (US);

Jennifer Lynn Knight, Jersey City, NJ (US);

Gabrielle R. Kolakowski, Longmont, CO (US);

Manoj Kumar, Longmont, CO (US);

Katelyn Frances Long, Lafayette, CO (US);

Christopher Glenn Mayne, Boulder, CO (US);

David L. McElligott, Bothell, WA (US);

Johnathan Alexander McLean, Indianapolis, IN (US);

Loredana Puca, New York, NY (US);

Kannan Karukurichi Ravi, Fords, NJ (US);

Daniel Lee Severance, San Diego, CA (US);

Michael Brian Welch, Westminister, CO (US);

Tien Widjaja, Lafayette, CO (US);

Assignee:

Petra Pharma Corporation, New York, NY (US);

Attorney:

Joseph Pletcher

Primary Examiner:

Rebecca L Anderson

Int. Cl.
CPC ...
C07D 405/04 (2006.01); C07D 405/14 (2006.01); C07D 491/056 (2006.01);
U.S. Cl.
CPC ...
C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 491/056 (2013.01);
Abstract

The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I): or a prodrug, solvate, enantiomer, stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, R, R, R, W, X, Y, s, and Ring A are as described herein.

Find Patent Forward Citations

Anderson, Erin. (2023). Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease (U.S. Patent No. 11649227). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11649227

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…